Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revive Therapeutics Ltd
C.RVV
Alternate Symbol(s):
RVVTF
Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is...
evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:RVV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(12)
•••
ElBorto
X
View Profile
View Bullboard History
Post by
ElBorto
on Nov 23, 2024 4:43pm
Psilocybin in the Treatment of Neurological Brain Injury
https://stockhouse.com/news/press-releases/2024/11/12/revive-therapeutics-announces-publication-demonstrating-novel-therapeutic
(12)
•••
RBLComm
X
View Profile
View Bullboard History
Post by
RBLComm
on Oct 31, 2024 8:21am
NEWS: Revive Therapeutics Provides Update on Research...
Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure READ MORE
(27)
•••
superfido10
X
View Profile
View Bullboard History
Comment by
superfido10
on Jul 04, 2024 10:01am
RE:RE: June 10, 2024 (GLOBE NEWSWIRE)
DOA. RIP
(10)
•••
hk1966
X
View Profile
View Bullboard History
Comment by
hk1966
on Jun 26, 2024 10:13pm
RE: June 10, 2024 (GLOBE NEWSWIRE)
AKA go pound salt you'll never get approved
(95)
•••
G1945V
X
View Profile
View Bullboard History
Post by
G1945V
on Jun 11, 2024 5:15am
June 10, 2024 (GLOBE NEWSWIRE)
Revive Therapeutics Provides Update From FDA Meeting for Long COVID Diagnostic Product "The FDA has determined that the Product should follow the De Novo regulatory pathway, and the Company
...more
(5)
•••
adoubleyou
X
View Profile
View Bullboard History
Post by
adoubleyou
on May 03, 2024 6:52pm
Next week's live was canceled per ftmig Twitter
Rvv posted on their handle for X that they will schedule something soon on a different platform.
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on May 02, 2024 7:57pm
Rescheduled - Wednesday May 8th at 2pm ET.
https://twitter.com/FTMInvest/status/1786167849834127412
(5)
•••
adoubleyou
X
View Profile
View Bullboard History
Post by
adoubleyou
on May 02, 2024 7:55pm
Mike frank to go live Wednesday may 8th at 7pm et
Apologies for our failed x space earlier with Revive_RVV RVV CEO Michael Frank. For all that were tuned in we hope you weren't too inconvenienced and we hope to make it up to those
...more
(95)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on May 02, 2024 3:38pm
RE:An Overview & Q&A with CEO Michael Frank May 2nd 4pm
Is the 4 PM EDT Q&A strictly for X subscribers? G1945V
(3)
•••
Tesla888
X
View Profile
View Bullboard History
Post by
Tesla888
on Apr 29, 2024 2:45pm
An Overview & Q&A with CEO Michael Frank May 2nd 4pm
Link - https://twitter.com/ftminvest/status/1784693118308122941?s=46&t=LsRlg0oC9EbPON1oBKpUbw
(3)
•••
Tesla888
X
View Profile
View Bullboard History
Post by
Tesla888
on Apr 18, 2024 8:19am
$RVV - FDA mtg June 7th
https://ca.finance.yahoo.com/news/revive-therapeutics-announces-fda-acceptance-110000050.html
(3)
•••
Tesla888
X
View Profile
View Bullboard History
Post by
Tesla888
on Apr 02, 2024 8:36am
$RVV News
https://ca.finance.yahoo.com/news/revive-therapeutics-provides-psilocybin-clinical-113000679.html
(3)
•••
Tesla888
X
View Profile
View Bullboard History
Post by
Tesla888
on Mar 19, 2024 9:01pm
$RVV - we get hour money back ? Hope so !!
https://ca.finance.yahoo.com/news/revive-therapeutics-submit-type-c-110000338.html
(3214)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Mar 12, 2024 8:48am
Revive Therapeutics Provides Corporate Update
TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research
...more
(3214)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Jan 10, 2024 11:26am
Revive Therapeutics Successfully Completes Development
TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >